Comparison of Drainage Methods in Minimally Invasive Esophagectomy (DEMURE）
NCT ID: NCT07004634
Last Updated: 2025-06-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
75 participants
INTERVENTIONAL
2025-04-30
2026-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Traditional Three-incision Esophagectomy Versus Minimally Invasive Thorascopic and Laparoscopic Esophagectomy
NCT02448966
The Safety and Efficacy of "3-Hole" Subxiphorid Approach in the Treatment of Anterior Mediastinal Tumor
NCT02317224
Two-field Versus Three-field Lymphadenectomy in Thoracic Esophageal Carcinoma Without Cervical Lymph Node Involvement
NCT02448953
Prevention and Treatment of Early Postoperative Atelectasis Using The MetaNeb System in Patients Underwent Esophagectomy
NCT07284056
The Impact of Different Anticoagulant Therapy on Hemorrhage and Coagulation After Thoracic Surgery
NCT01267305
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Abdominal mediastinal tube
Transperitoneal mediastinal drainage was performed for postoperative management of the patient.
Abdominal mediastinal tube
Transperitoneal mediastinal drainage was performed for postoperative management of the patient.
Chest mediastinal tube
Transthoracic mediastinal drainage was performed for postoperative management of the patient.
Chest mediastinal tube
Transthoracic mediastinal drainage was performed for postoperative management of the patient.
Chest tube + chest mediastinal tube
Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.
Chest tube + chest mediastinal tube
Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Chest mediastinal tube
Transthoracic mediastinal drainage was performed for postoperative management of the patient.
Abdominal mediastinal tube
Transperitoneal mediastinal drainage was performed for postoperative management of the patient.
Chest tube + chest mediastinal tube
Chest tube insertion combined with transthoracic mediastinal drainage was performed for postoperative management of the patient.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Pathologically confirmed esophageal cancer requiring three-incision esophagectomy (cervical, thoracic, and abdominal incisions)
* ASA physical status class I-III
Exclusion Criteria
* Severe cardiopulmonary dysfunction (e.g., FEV1 \<50%)
* Coagulation disorders or patients undergoing reoperation
* Intraoperative findings of extensive pleural adhesions, combined resection of adjacent organs, or other conditions deemed by the investigator to warrant exclusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruijin Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hecheng Li, PhD, MD
Role: PRINCIPAL_INVESTIGATOR
Ruijin Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RTS-026
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.